Related Experiment Video

Updated: Aug 19, 2026

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions
10:08

Co-culture of Glioblastoma Stem-like Cells on Patterned Neurons to Study Migration and Cellular Interactions

Published on: February 24, 2021

Molecular events implicated in brain tumor angiogenesis and invasion

D Zagzag1, D R Friedlander, B Margolis

  • 1Division of Neuropathology, Department of Pathology, New York University School of Medicine, New York, NY 10016, USA.

Pediatric Neurosurgery
|October 12, 2000
PubMed

Insights

This study investigates key molecular factors—angiopoietins, hypoxia-inducible factor-1, and focal adhesion kinase—that drive brain tumor invasion and blood vessel growth in the central nervous system.

Area of Science:

  • Neuro-oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Brain tumor invasion and angiogenesis are critical for malignant central nervous system tumor growth.
  • Several molecular factors contribute to these complex processes.
  • Understanding these mechanisms is vital for developing effective therapies.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying brain tumor invasion and angiogenesis.
  • To focus on the roles of angiopoietins, hypoxia-inducible factor-1 (HIF-1), and focal adhesion kinase (FAK) in tumor progression.

Main Methods:

  • Literature review and analysis of existing studies on molecular factors in brain tumors.
  • Focus on the specific functions of angiopoietins, HIF-1, and FAK in tumor vascularization and cell migration.

Main Results:

  • Angiopoietins regulate vascular development, impacting tumor angiogenesis.
  • Hypoxia-inducible factor-1 (HIF-1) up-regulates genes, including vascular endothelial growth factor (VEGF), under hypoxic conditions, promoting angiogenesis.
  • Focal adhesion kinase (FAK) is associated with both tumor cell infiltration and angiogenesis.

Conclusions:

  • Angiopoietins, HIF-1, and FAK are pivotal molecular players in central nervous system tumor progression.
  • Targeting these factors may offer therapeutic strategies to inhibit brain tumor invasion and angiogenesis.

More Related Videos

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells05:02

Modeling Brain Metastasis Via Tail-Vein Injection of Inflammatory Breast Cancer Cells

Published on: February 4, 2021

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis09:33

Preparation Of Neovascular Tissues from Human Glioma Tissues for Quantitative Proteomics Analysis of Tumor Angiogenesis

Published on: March 20, 2026

Related Concept Videos

Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...